A Retrospective Cohort Study of the 2018 Angiotensin Receptor Blocker Recalls and Subsequent Drug Shortages in Patients With Hypertension.

Joshua W Devine Mina Tadrous Inmaculada Hernandez Katherine Callaway KimScott D RothenbergerNandita MukhopadhyayWalid F GelladKatie J Suda

Published in: Journal of the American Heart Association (2023)

The valsartan recall and shortage affected hypertensive patients. Local- and national-level systems need to be enhanced to protect patients from drug shortages by providing safe and reliable medication alternatives.

Keyphrases

blood pressure
hypertensive patients
end stage renal disease
ejection fraction
newly diagnosed
adverse drug
healthcare
emergency department
angiotensin ii
drug induced
patient reported outcomes